Provided by Tiger Trade Technology Pte. Ltd.

SPYRE THERAPEUTICS INC

90.90
+2.192.47%
Volume:419.35K
Turnover:37.50M
Market Cap:8.01B
PE:-45.22
High:91.15
Open:89.99
Low:87.91
Close:88.71
52wk High:110.18
52wk Low:14.51
Shares:88.17M
Float Shares:80.98M
Volume Ratio:0.49
T/O Rate:0.52%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.0100
EPS(LYR):-1.9755
ROE:-22.98%
ROA:-19.81%
PB:8.40
PE(LYR):-46.01

Loading ...

May 05, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 01, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 01, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 23, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Apr 17, 2026

Major Issues Report

Form 8-K - Current report
Apr 13, 2026

Major Issues Report

Form 8-K - Current report
Apr 13, 2026

Major Issues Report

Form 8-K - Current report
Apr 01, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 03, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 02, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 25, 2026

Correspondence

Form CORRESP - Correspondence
Feb 19, 2026

Major Issues Report

Form 8-K - Current report
Feb 19, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 19, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jan 12, 2026

Major Issues Report

Form 8-K - Current report
Nov 05, 2025

Major Issues Report

Form 8-K - Current report
Nov 04, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 15, 2025

Major Issues Report

Form 8-K - Current report
Oct 14, 2025

Major Issues Report

Form 8-K - Current report